Latest Arbitration Decision Rules in Favor of AHF
Ruling validates antitrust theory, pushes antitrust arbitration against Prime Therapeutics forward.
AIDS Healthcare Foundation (AHF), a provider of healthcare to people living with HIV/AIDS, acquired a legal victory in an American Arbitration Association arbitration against Prime Therapeutics LLC, a pharmacy benefit manager (PBM). Per the ruling, AHF will be allowed to move forward against Prime on claims of antitrust violations and other civil wrongs.
In late June, Arbitrator David R. Cohen, Esq., issued his ruling granting in part, denying in part Prime’s motion to dismiss AHF’s case. Arbitrator Cohen retained five of AHF’s seven claims, dismissing only two. This originally dates back to April 2020, when reportedly, Prime had been deliberately aligning its pharmacy reimbursement rates with those of another PBM, Express Scripts, Inc, competing on price to attract pharmacies into provider networks.
"The arbitrator’s ruling is particularly noteworthy for validating AHF’s theory of per-se (automatic) antitrust violations in the nature of price-fixing by Prime. AHF is now preparing to prove those claims in the next phase of the arbitration," says Jonathan M. Eisenberg, deputy general counsel for AHF. "Arbitrator Cohen also deemed unreasonable and refused to enforce Prime’s contractual one-year statute of limitations that might have precluded any of AHF’s claims from even being heard."
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
